A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections
Clinical trial NCT05030324 · COMPLETED
Trial details
- NCT number
- NCT05030324
- Sponsor
- Valenta Pharm JSC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2022-05-04
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.